1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-126665 DMEA-PNU-159682

ADC Cytotoxin

Cancer

2019-11 DMEA-PNU-159682
HY-100132 P300/CBP-IN-5

Histone Acetyltransferase

Cancer

2019-11 P300/CBP-IN-5
HY-130243 RORγt Inverse agonist 6

ROR

Inflammation/Immunology

2019-11 RORγt Inverse agonist 6
HY-129610 KB02-SLF

PROTAC

Cancer

2019-11 KB02-SLF
HY-69220 7-Octynoic acid

PROTAC Linker

Cancer

2019-11 7-Octynoic acid
HY-43722 Lenalidomide-Br

E3 Ligase Ligand-Linker Conjugate

Cancer

2019-11 Lenalidomide-Br
HY-129608 Lenalidomide-acetylene-C5-COOH

E3 Ligase Ligand-Linker Conjugate

Cancer

2019-11 Lenalidomide-acetylene-C5-COOH
HY-129601 MYCi975

c-Myc

Cancer;

Inflammation/Immunology

2019-11 MYCi975
HY-130242 PXS-5120A

Others

Inflammation/Immunology

2019-11 PXS-5120A
HY-129545 DS-1001b

Isocitrate Dehydrogenase (IDH)

Cancer

2019-11 DS-1001b
HY-126674 Mal-Phe-C4-Val-Cit-PAB-DMEA

ADC Linker

Cancer

2019-11 Mal-Phe-C4-Val-Cit-PAB-DMEA
HY-126671 Mal-Phe-C4-Val-Cit-PAB

ADC Linker

Cancer

2019-11 Mal-Phe-C4-Val-Cit-PAB
HY-130103 Ald-Phe-amido-PEG2-C2-Pfp ester

ADC Linker

Cancer

2019-11 Ald-Phe-amido-PEG2-C2-Pfp ester
HY-111588 Xanthoangelol

Others

Infection;

Inflammation/Immunology

2019-11 Xanthoangelol
HY-130104 Ald-Phe-amido-PEG2-C2-NHS ester

ADC Linker

Cancer

2019-11 Ald-Phe-amido-PEG2-C2-NHS ester
HY-P1832A PTD-p65-P1 Peptide TFA

NF-κB

Cancer;

Inflammation/Immunology

2019-11 PTD-p65-P1 Peptide TFA
HY-114872 SLF

Ligand for Target Protein for PROTAC; FKBP

Cancer

2019-11 SLF
HY-126693 SC-VC-PAB-DM1

Drug-Linker Conjugates for ADC

Cancer

2019-11 SC-VC-PAB-DM1
HY-129611 Bromelain

Apoptosis

Cancer;

Inflammation/Immunology

2019-11 Bromelain
HY-P1731B Tirzepatide hydrochloride

Glucagon Receptor

Metabolic Disease

2019-11 Tirzepatide hydrochloride